Browse > Article
http://dx.doi.org/10.4062/biomolther.2018.176

Resveratrol: Twenty Years of Growth, Development and Controversy  

Pezzuto, John M. (Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University)
Publication Information
Biomolecules & Therapeutics / v.27, no.1, 2019 , pp. 1-14 More about this Journal
Abstract
Resveratrol was first isolated in 1939 by Takaoka from Veratrum grandiflorum O. Loes. Following this discovery, sporadic descriptive reports appeared in the literature. However, spurred by our seminal paper published nearly 60 years later, resveratrol became a household word and the subject of extensive investigation. Now, in addition to appearing in over 20,000 research papers, resveratrol has inspired monographs, conferences, symposia, patents, chemical derivatives, etc. In addition, dietary supplements are marketed under various tradenames. Once resveratrol was brought to the limelight, early research tended to focus on pharmacological activities related to the cardiovascular system, inflammation, and cancer but, over the years, the horizon greatly expanded. Around 130 human clinical trials have been (or are being) conducted with varying results. This may be due to factors such as disparate doses (ca. 5 to 5,000 mg/day) and variable experimental settings. Further, molecular targets are numerous and a dominant mechanism is elusive or nonexistent. In this context, the compound is overtly promiscuous. Nonetheless, since the safety profile is pristine, and use as a dietary supplement is prevalent, these features are not viewed as detrimental. Given the ongoing history of resveratrol, it is reasonable to advocate for additional development and further clinical investigation. Topical preparations seem especially promising, as do conditions that can respond to anti-inflammatory action and/or direct exposure, such as colon cancer prevention. Although the ultimate fate of resveratrol remains an open question, thus far, the compound has inspired innovative scientific concepts and enhanced public awareness of preventative health care.
Keywords
Mechanism; Discovery; Anti-inflammation; Clinical value; Utilization;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Mukhopadhyay, P., Mukherjee, S., Ahsan, K., Bagchi, A., Pacher, P. and Das, D. K. (2010) Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One 5, e15705.   DOI
2 Mukhopadhyay, P., Das, S., Ahsan, M. K., Otani, H. and Das, D. K. (2012) Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergistic effects of resveratrol and gamma-tocotrienol. J. Cell. Mol. Med. 16, 2504-2517.   DOI
3 Ndiaye, M., Philippe, C., Mukhtar, H. and Nihal Ahmad, N. (2011) The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges. Arch. Biochem. Biophys. 508, 164-170.   DOI
4 Niles, R. M., Cook, C. P., Meadows, G. G., Fu, Y. M., McLaughlin, J. L. and Rankin, G. O. (2006) Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. J. Nutr. 136, 2542-2546.   DOI
5 Osmond, G. W., Masko, E. M., Tyler, D. S., Freedland, S. J. and Pizzo, S. (2013) In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4'-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. J. Surg. Res. 179, e141-e148.   DOI
6 Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., Qiu, X., Stockman, B., Thanabal, V., Varghese, A., Ward, J., Withka, J. and Ahn, K. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 285, 8340-8351.   DOI
7 Palomera-Avalos, V., Grinan-Ferre, C., Puigoriol-Ilamola, D., Camins, A., Sanfeliu, C., Canudas, A. M. and Pallas, M. (2017) Resveratrol protects SAMP8 brain under metabolic stress: focus on mitochondrial function and Wnt pathway. Mol. Neurobiol. 54, 1661-1676.   DOI
8 Seyyedebrahimi, S., Khodabandehloo, H., Esfahani, E. N. and Meshkani, R. (2018) The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. Acta Diabetologica 55, 341-353.   DOI
9 Sharma, S., Kulkarni, S. K. and Chopra, K. (2006) Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J. Exp. Biol. 44, 566-569.
10 Sharma, S., Kulkarni, S. K. and Chopra, K. (2007) Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam. Clin. Pharmacol. 21, 89-94.   DOI
11 Steele, V. E., Lubet, R. A. and Moon, R. C. (2005) Preclinical Animal Models for the Development of Cancer Chemoprevention Drugs. Humana Press Inc., Totowa, NJ.
12 Shrotriya, S., Tyagi, A., Deep, G., Orlicky, D. J., Wisell, J., Wang, X. J., Sclafani, R. A., Agarwal, R. and Agarwal, C. (2015) Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses. Mol. Carcinog. 54, 291-300.   DOI
13 Smoliga, J. M., Baur, J. A. and Hausenblas, H. A. (2011) Resveratrol and health-a comprehensive review of human clinical trials. Mol. Nutr. Food Res. 55, 1129-1141.   DOI
14 Soleas, G. J., Grass, L., Josephy, P. D., Goldberg, D. M. and Diamandis, E. P. (2002) A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin. Biochem. 35, 119-124.   DOI
15 Szaefer, H., Krajka-Kuzniak, V. and Baer-Dubowska, W. (2008) The effect of initiating doses of benzo[a]pyrene and 7,12-dimethylbenz[a] anthracene on the expression of PAH activating enzymes and its modulation by plant phenols. Toxicology 251, 28-34.   DOI
16 Huang, W., Chen, Z., Wang, O., Lin, M., Wu, S., Yan, Q., Wu, F., Yu, X., Xie, X., Li, G., Xu, Y. and Pan, J. (2013) Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab. Brain Dis. 28, 585-595.   DOI
17 Hao, Y. Q., Huang, W. X., Feng, H. X., Zhang, G. H., Ning, X. H., Li, H. G., Hao, C. G. and Li, Z. H. (2013b) Study of apoptosis related factors regulatory mechanism of resveratrol to human skin squamous cell carcinoma A431 xenograft in nude mice. Zhonghua Yi Xue Za Zhi 93, 464-468.
18 Hoshino, J., Park, E. J., Kondratyuk, T. P., Marler, L., Pezzuto, J. M., van Breemen, R. B., Mo, S., Li ,Y. and Cushman, M. (2010) Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J. Med. Chem. 53, 5033-5043.   DOI
19 Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B. and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.   DOI
20 Hunter, P. (2012) The inflammation theory of disease. EMBO Rep. 13, 968-970.   DOI
21 Park, E. J. and Pezzuto, J. M. (2015) The pharmacology of resveratrol in animals and humans. Biochim. Biophys. Acta 1852, 1071-1113.   DOI
22 Hurley, L. L., Akinfiresoye, L., Kalejaiye, O. and Tizabi, Y. (2014) Antidepressant effects of resveratrol in an animal model of depression. Behav. Brain Res. 268, 1-7.   DOI
23 Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W., Fong, H. H., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.   DOI
24 Jang, M. and Pezzuto, J. M. (1998) Effects of resveratrol on 12-O-tetradecanoylphorbol- 13-acetate-induced oxidative events and gene expression in mouse skin. Cancer Lett. 134, 81-89.   DOI
25 Carboni, L. (2013) Peripheral biomarkers in animal models of major depressive disorder. Dis. Markers 35, 33-41.   DOI
26 Cho, K. S., Lee, E. J., Kwon, K. J., Gonzales, E. L., Kim, Y. B., Cheong, J. H., Bahn, G. H., Lee, J., Han, S. H., Kim, Y. T. and Shin, C. Y. (2014) Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons. Food Funct. 5, 951-960.   DOI
27 Pan, Y., Zhang, H., Zheng, Y., Zhou, J., Yuan, J., Yu, Y. and Wang, J. (2017) Resveratrol exerts antioxidant effects by activating SIRT2 to deacetylate Prx1. Biochemistry 56, 6325-6328.   DOI
28 Park, D. W., Baek, K., Kim, J. R., Lee, J. J., Ryu, S. H., Chin, B. R. and Baek, S. H. (2009) Resveratrol inhibits foam cell formation via NADPH oxidase 1- mediated reactive oxygen species and monocyte chemotactic protein-1. Exp. Mol. Med. 41, 171-179.   DOI
29 Patel, K. R., Brown, V. A., Jones, D. J. L., Britton, R. G., Hemingway, D., Miller, A. S., West, K. P., Booth, T. D., Perloff, M., Crowell, J. A., Brenner, D. E., Steward, W. P., Gescher, A. J. and Brown, K. (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70, 7392-7399.   DOI
30 Patel, K. R., Andreadi, C., Britton, R. G., Horner-Glister, E., Karmokar, A., Sale, S., Brown, V. A., Brenner, D. E., Singh, R., Steward, W. P., Gescher, A. J. and Brown, K. (2013) Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Sci. Trans. Med. 5, 205ra133.   DOI
31 Penumathsa, S. V., Koneru, S., Samuel, S. M., Maulik, G., Bagchi, D., Yet, S. F., Menon, V. P. and Maulik, N. (2008) Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor. Free Radic. Biol. Med. 45, 1027-1034.   DOI
32 Pezzuto, J. M. (1997) Plant-derived anticancer agents. Biochem. Pharmacol. 53, 121-133.   DOI
33 Cichocki, M., Paluszczak, J., Szaefer, H., Piechowiak, A., Rimando, A. M. and Baer-Dubowska, W. (2008) Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. Mol. Nutr. Food Res. 52, S62-S70.   DOI
34 Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., Jensen, L. J. and von Mering, C. (2017) The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362-D68.   DOI
35 Takaoka, M. (1939) Resveratrol, a new phenolic compound, from Veratrum grandiflorum. J. Chem. Soc. Jpn. 60, 1090-1100.
36 Chowdhury, S. K. R., Smith, D. R., Saleh, A., Schapansky, J., Marquez, A., Gomes, S., Akude, E., Morrow, D., Calcutt, N. A. and Fernyhough, P. (2012) Impaired adenosine monophosphate-activated protein kinase signaling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135, 1751-1766.   DOI
37 ClinicalTrials.gov (2018a) Available from: https://clinicaltrials.gov/ct2/results/map?term=resveratrol&map=) [accessed 2018 Sep 4].
38 ClinicalTrials.gov (2018b) Available from: https://clinicaltrials.gov/ct2/results?cond=colon+cancer&term=resveratrol&cntry=&state=&city=&dist=) [accessed 2018 Oct 3].
39 Cragg, G. M. and Pezzuto, J. M. (2016) Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med. Princ. Pract. 25 Suppl 2, 41-59.   DOI
40 Csiszar, A., Labinskyy, N., Pinto, J. T., Ballabh, P., Zhang, H., Losonczy, G., Pearson, K., de Cabo, R., Pacher, P., Zhang, C. and Ungvari, Z. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297, H13-H20.   DOI
41 Afaq, F., Adhami, V. M. and Ahmad, N. (2003) Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 186, 28-37.   DOI
42 Aggarwal, B. B. and S. Shishodia, S. (2006) Resveratrol in Health and Disease, Marcel Dekker, Inc., New York.
43 Wan, D., Zhou, Y., Wang, K., Hou, Y., Hou, R. and Ye, X. (2016) Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res. Bull. 121, 255-262.   DOI
44 Tameda, M., Sugimoto, K., Shiraki, K., Inagaki, Y., Ogura, S., Kasai, C., Yoneda, M., Okamoto, R., Yamamoto, N., Takei, Y., Ito, M. and Nobori, T. (2014) Resveratrol sensitizes HepG2 cells to TRAIL-induced apoptosis. Anticancer Drugs 25, 1028-1034.   DOI
45 Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H. Y., Ma, Q. Y., Mukhopadhyay, P., Nalini, N., Pezzuto, J. M., Richard, T., Shukla, Y., Surh, Y. J., Szekeres, T., Szkudelski, T., Walle, T. and Wu, J. M. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 6, e19881.   DOI
46 Villa-Cuesta, E., Boylan, J. M., Tatar, M. and Gruppuso, P. A. (2011) Resveratrol inhibits protein translation in hepatic cells. PLoS ONE 6, e29513.   DOI
47 Wightman, E. L., Reay, J. L., Haskell, C. F., Williamson, G., Dew, T. P. and Kennedy, D. O. (2014) Effects of resveratrol alone or in combinationwith piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. Br. J. Nutr. 112, 203-213.   DOI
48 Asensi, M., Medina, I., Ortega, A., Carretero, J., Bano, M. C., Obrador, E. and Estrela, J. M. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33, 387-398.   DOI
49 Jing, Y. H., Chen, K. H., Kuo, P. C., Pao, C. C. and Chen, J. K. (2013) Neurodegeneration in streptozotocin-induced diabetic rats is attenuated by treatment with resveratrol. Neuroendocrinology 98, 116-127.   DOI
50 Johnson, J. M., Nihal, M., Siddiqui, I. A., Scarlett, C. O., Bailey, H. H., Mukhtar, H. and Ahmad, H. (2011a) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 55, 1169-1176.   DOI
51 Ayala, F. (2011) Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am. J. Clin. Dermatol. 12, 133-141.   DOI
52 Aziz, M. H., Reagan-Shaw, S., Wu, J., Longley, B. J. and Ahmad, N. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J. 19, 1193-1195.   DOI
53 Back, J. H., Zhu, Y., Calabro, A., Queenan, C., Kim, A. S., Arbesman, J. and Kim, A. L. (2012) Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis. Photochem. Photobiol. 88, 1165-1172.   DOI
54 Bashmakov, Y. K., Assaad-Khalil, S. H., Seif, M. A., Udumyan, R., Megallaa, M., Rohoma, K. H., Zeitoun, M. and Petyaev, I. M. (2014) Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinol. 2014, 816307.
55 Baxter, R. A. (2008) Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J. Cosmet. Dermatol. 7, 2-7.   DOI
56 Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. and Bourne, P. E. (2000) The protein data bank. Nucleic Acids Res. 28, 235-242.   DOI
57 Bhat, K. P. L., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C. and Pezzuto, J. M. (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61, 7456-7463.
58 Kalra, N., Roy, P., Prasad, S. and Shukla, Y. (2008) Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci. 82, 348-358.   DOI
59 Johnson, W. D., Morrissey, R. L. Usborne, A. L., Kapetanovic, I., Crowell, J. A., Muzzio, M. and McCormick, D. L. (2011b) Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem. Toxicol. 49, 3319-3327.   DOI
60 Juhasz, B., Mukherjee, S. and Das, D. K. (2010) Hormetic response of resveratrol against cardioprotection. Exp. Clin. Cardiol. 15, e134-e138.
61 Kapadia, G. J., Azuine, M. A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T. and Nishino, H. (2002) Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 45, 499-505.   DOI
62 Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A. and Haskell, C. F. (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 91, 1590-1597.   DOI
63 Boily, G., He, X. H., Pearce, B., Jardine, K. and McBurney, M. W. (2009) Sirt1-nullmice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 28, 2882-2893.   DOI
64 Bhat, K. P. and Pezzuto, J. M. (2002) Cancer chemopreventive activity of resveratrol. Ann. N.Y. Acad. Sci. 957, 210-229.   DOI
65 Bhatt, J. K., Thomas, S. and Nanjan, M. J. (2012) Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 32, 537-541.   DOI
66 Bhattacharya, S., Darjatmoko, S. R. and Polans, A. S. (2011) Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB. Melanoma Res. 21, 180-187.   DOI
67 Bomgardner, M. M. (2017) Reviving resveratrol. Chem. Eng. News 95, 38-39.
68 Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., Brown, K., Steward, W. P., Gescher. A. J. and Brenner, D. E. (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res. 70, 9003-9011.   DOI
69 Buhrmann, C., Shayan, P., Popper, B., Goel, A. and Shakibaei, M. (2016) Sirt1 is required for resveratrol-mediated chemopreventive effects in colorectal cancer cells. Nutrients 8, 145.   DOI
70 Calabrese, E. J., Mattson, M. P. and Calabrese, V. (2010) Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum. Exp. Toxicol. 29, 980-1015.   DOI
71 Pezzuto, J. M., Kondratyuk, T. P. and Olgas, T. (2013) Resveratrol derivatives: a patent review (2009-2012). Expert Opin. Ther. Pat. 23, 1529-1546.   DOI
72 Cao, C., Lu, S., Kivlin, R., Wallin, B., Card, E., Bagdasarian, A., Tamakloe, T., Wang, W. J., Song, X., Chu, W. M., Kouttab, N., Xu, A. and Wan, Y. (2009) SIRT1 confers protection against UVB- and $H_2O_2$-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J. Cell. Mol. Med. 13, 3632-3643.   DOI
73 Cao, D., Wang, M., Qiu, X., Liu, D., Jiang, H., Yang, N. and Xu, R. M. (2015) Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes Dev. 29, 1316-1325.   DOI
74 Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P. and Auwerx, J. (2009) AMPK regulates energy expenditure by modulating $NAD^+$ metabolism and SIRT1 activity. Nature 458, 1056-1060.   DOI
75 Pezzuto, J. M., Kosmeder, J.W., II, Park, E. J., Lee, S. K., Cuendet, M., Gills, J., Bhat, K., Grubjesic, S., Park, H.-S., Mata-Greenwood, E., Tan, Y. M., Yu, R., Lantvit, D. D. and Kinghorn, A. D. (2005) Characterization of natural product chemopreventive agents. In Cancer Chemoprevention, Volume 2: Strategies for Cancer Chemoprevention (G.J. Kelloff, E.T. Hawk, and C.C. Sigman, Eds.), pp. 3-37. Humana Press Inc., Totowa, New Jersey.
76 Pezzuto, J. M. (2011) The phenomenon of resveratrol: redefining the virtues of promiscuity. Ann. N.Y. Acad. Sci. 1215, 123-130.   DOI
77 Pollack, A. Glaxo says compound in wine may fight aging (https://www.nytimes.com/2008/04/23/business/23wine.html) accessed October 3, 2018.
78 Popat, R., Plesner, T., Davies, F., Cook, G., Cook, M., Elliott, P., Jacobson, E., Gumbleton, T., Oakervee, H., and Cavenagh, J. (2013) A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br. J. Haematol. 160, 714-717.   DOI
79 Prabhakar, O. (2013) Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats. Naunyn Schmiedebergs Arch. Pharmacol. 386, 705-710.   DOI
80 Price, D. D., Finniss, D. G. and Benedetti, F. (2008) A comprehensive review of the placebo effect: recent advances and current thought. Ann. Rev. Psychol. 59, 565-590.   DOI
81 Ratz-Lyko, A. and Arct, J. (2018) Resveratrol as an active ingredient for cosmetic and dermatological applications: a review. J. Cosmet. Laser Ther. doi: 10.1080/14764172.2018.1469767.   DOI
82 Das, S., Tosaki, A., Bagchi, D., Maulik, N. and Das, D. K. (2006) Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling. J. Pharmacol. Exp. Ther. 317, 980-988.   DOI
83 Wu, J. M. and Hsieh, T.-C. (2018) Resveratrol: State-of-the-Art Science and Health Applications. World Scientific Publishing, Singapore.
84 Yusuf, Y., Nasti, T. H., Meleth, S. and Elmets, C. A. (2009) Resveratrol enhances cell-mediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis. Mol. Carcinog. 48, 713-723.   DOI
85 Xia, N., Strand, S., Schlufter, F., Siuda, D., Reifenberg, G., Kleinert, H., Forstermann, U. and Li, H. (2013) Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol. Nitric Oxide 32, 29-35.   DOI
86 Damian, J. P., Acosta, V., Da Cuna, M., Ramirez, I., Oddone, N., Zambrana, A., Bervejillo, V. and J. C. Benech, J. C. (2014) Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp. Anim. 63, 277-287.   DOI
87 Das, S., Alagappan, V. K., Bagchi, D., Sharma, H. S., Maulik, N. and Das, D. K. (2005) Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: a potential mechanism for resveratrol preconditioning of the heart. Vascul. Pharmacol. 42, 281-289.   DOI
88 Do, G. M., Jung, U. J., Park, H. J., Kwon, E. Y., Jeon, S. M., McGregor, R. A. and Choi, M. S. (2012) Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Mol. Nutr. Food Res. 56, 1282-1291.   DOI
89 El-Mowafy, A. M., Alkhalaf, M. and Nassar, N. N. (2009) Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes. Int. J. Cardiol. 136, 263-269.   DOI
90 Escote, X., Miranda, M., Menoyo, S., Rodriguez-Porrata, B., Carmona-Gutierrez, D., Jungwirth, H., Madeo, F., Cordero, R. R., Mas, A., Tinahones, F., Clotet, J. and Vendrell, J. (2012) Resveratrol induces antioxidant defence via transcription factor Yap1p. Yeast 29, 251-263.   DOI
91 Kumar, A., Park, E.-J. and Pezzuto, J. M. (2018) Chapter 3. Resveratrol as an activator or inhibitor of enzymes and proteins. In Resveratrol: State-of-the-Art Science and Health Applications (J. M. Wu and T.-C. Hsieh, Eds.), pp. 55-113. World Scientific Publishing, Singapore.
92 Kim, K. H., Back, J. H., Zhu, Y., Arbesman, J., Athar, M., Kopelovich, L., Kim, A. L. and Bickers, D. R. (2011) Resveratrol targets transforming growth factor-${\beta}2$ signaling to block UV-induced tumor progression. J. Invest. Dermatol. 131, 195-202.   DOI
93 Kjaer, T. N., Ornstrup, M. J., Poulsen, M. M., Stodkilde-Jorgensen, H., Jessen, N., Jorgensen, J. O. L., Richelsen, B. and Pedersen, S. B. (2017) No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 102, 1642-1651.   DOI
94 Evans, H. M., Howe, P. R. C. and Wong, R. H. X. (2017) Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial. Nutrients 9, E27.   DOI
95 Kowalczyk, M. C., Kowalczyk, P., Tolstykh, O., Hanausek, M., Walaszek, Z. and Slaga, T. J. (2010) Synergistic effects of combined phytochemicals and skin cancer prevention in SENCAR mice. Cancer Prev. Res. 3, 170-178.   DOI
96 Kowalczyk, M. C., Junco, J. J., Kowalczyk, P., Tolstykh, O., Hanausek, M., Slaga, T. J. and Walaszek, Z. (2013) Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. Int. J. Oncol. 43, 911-918.   DOI
97 Krishnan, V. and Nestler, E. J. (2011) Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 7, 121-147.   DOI
98 Kumar, A., Kaundal, R. K., Iyer, S. and Sharma, S. S. (2007) Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80, 1236-1244.   DOI
99 Kundu, J. K., Chun, K. S., Kim, S. O. and Surh, Y. J. (2004) Resveratrol inhibits phorbol ester-induced cyclooxygenase-2 expression in mouse skin: MAPKs and AP-1 as potential molecular targets. Biofactors 21, 33-39.   DOI
100 Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S., Forman, S. J., Jove, R., Riggs, A. D. and Yu, H. (2012) Acetylated STAT3 is crucial for methylation of tumor suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc. Natl. Acad. Sci. U.S.A. 109, 7765-7769.   DOI
101 Lee, T. H., Seo, J. O., Baek, S. H. and Kim, S. Y. (2014) Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in Guinea pig skin. Biomol. Ther. (Seoul) 22, 35-40.   DOI
102 Movahed, A., Nabipour, I., Louis, X. L., Thandapilly, S. J., Yu, L., Kalantarhormozi, M., Rekabpour, S. J. and Netticadan, T. (2013) Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid. Based Complement. Alternat. Med. 2013, 851267.
103 Ma, S. C., Zhang, H. P., Jiao, Y., Wang, Y. H., Zhang, H., Yang, X. L., Yang, A. N. and Jiang, Y. D. (2018) Homocysteine-induced proliferation of vascular smooth muscle cells occurs via PTEN hypermethylation and is mitigated by resveratrol. Mol. Med. Rep. 17, 5312-5319.
104 Maroon, J. (2009) The Longevity Factor: How Resveratrol and Red Wine Activate Genes for a Longer and Healthier Life. Atria Paperback, New York.
105 Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., Orihuela, C. J., Pletcher, S., Sharp, Z. D., Sinclair, D., Starnes, J. W., Wilkinson, J. E., Nadon, N. L. and Strong, R. (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191-201.
106 Moyano-Mendez, J. R., Fabbrocini, G., De Stefano, D., Mazzella, C., Mayol, L., Scognamiglio, I., Carnuccio, R., Ayala, F., La Rotonda, M. I. and De Rosa, G. (2014) Enhanced antioxidant effect of transresveratrol: potential of binary systems with polyethylene glycol and cyclodextrin. Drug Deve. Ind. Pharm. 40, 1300-1307.   DOI
107 Ruderman, N. B., Xu, X. J., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F. and Ido, Y. (2010) AMPK and SIRT1: a long-standing partnership? Am. J. Physiol. Endocrinol. Metab. 298, E751-E760.   DOI
108 Reagan-Shaw, S., Afaq, F., Aziz, M. H. and Ahmad, N. (2004) Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 23, 5151-5160.   DOI
109 Rogers, R. G. and Otis, J. S. (2017) Resveratrol-mediated expression of KLF15 in the ischemic myocardium is associated with an improved cardiac phenotype. Cardiovasc. Drugs Ther. 31, 29-38.   DOI
110 Roy, P., Kalra, N., Prasad, S., George, J. and Shukla, Y. (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm. Res. 26, 211-217.   DOI
111 Ruggeri, B. A., Camp, F. and Miknyoczki, S. (2014) Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem. Pharmacol. 87, 150-161.   DOI
112 Sardi, B. (2004) The Anti-Aging Pill. Here and Now Books, San Dimas, CA.
113 Sawda, C., Moussa, C. and Turner, R. S. (2017) Resveratrol for Alzheimer's disease. Ann. N.Y. Acad. Sci. 1403, 142-149.   DOI
114 Goh, S. S., Woodman, O. L., Pepe, S., Cao, A. H., Qin, C. and Ritchie, R. H. (2007) The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid. Redox. Signal 9, 101-113.   DOI
115 Schilder, Y. D., Heiss, E. H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D. and Dirsch, V. M. (2009) NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic. Biol. Med. 46, 1598-1606.   DOI
116 Schmatz, R., Mazzanti, C. M., Spanevello, R., Stefanello, N., Gutierres, J., Correa, M., da Rosa, M. M., Rubin, M. A., Chitolina Schetinger, M. R. and Morsch, V. M. (2009) Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 610, 42-48.   DOI
117 Fabbrocini, G., Staibano, S., De Rosa, G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, M. I., Longobardi, A., Mazzella, M., Siano, M., Pastore, F., De Vita, V., Vecchione, M. L. and Ayala, F. (2011) Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am. J. Clin. Dermatol. 12, 133-141.   DOI
118 Fu, Z. D., Cao, Y., Wang, K. F., Xu, S. F and Han, R. (2004) Chemopreventive effect of resveratrol to cancer. Ai Zheng 23, 869-873.
119 Gehm, B. D., McAndrews, J. M., Chien, P. Y and Jameson, J. L. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 14138-14143.   DOI
120 Gracia-Sancho, J., Villarreal, G., Jr., Zhang, Y. and Garcia-Cardena, G. (2010) Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc. Res.85, 514-519.   DOI
121 Guilford, J. M. and Pezzuto, J. M. (2011) Wine and health: a review. Am. J. Enol. Vitic. 62, 471-486.   DOI
122 Hao, Y., Huang, W., Liao, M., Zhu, Y., Liu, H., Hao, C., Liu, G., Zhang, G., Feng, H., Ning, X., Li, H. and Li, Z. (2013a) The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice. Fitoterapia 86, 84-91.   DOI
123 Guo, D., Xie, J., Zhao, J., Huang, T., Guo, X. and Song, J. (2018) Resveratrol protects early brain injury after subarachnoid hemorrhage by activating autophagy and inhibiting apoptosis mediated by the Akt/mTOR pathway. Neuroreport 29, 368-379.   DOI